Nov 26, 2025
Happy Thanksgiving
Happy Thanksgiving! The Macular Degeneration Association would like to express our gratitude for your support and thoughtfulness. “As we show our appreciation, we must remember that the highest form of…
Resources
Nov 26, 2025
Low Vision vs Legally Blind: What’s the difference?
Dr. Long, thank you for explaining the difference between low vision and legal blindness. Low vision vs. legally blind—what’s the difference? The terms “low vision” and “legally blind” are often…
Nov 25, 2025
New Stem Cell Therapy Trial Offers Hope for Millions Living with Untreatable Advanced Dry Macular Degeneration
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety issues are identified, the investigators plan to move on…
Nov 25, 2025
FDA approves Eylea HD for macular edema after retinal vein occlusion
By: Anthony DeFino Fact checked by: Nancy Hemphill, ELS, FAAO Key takeaways: The decision is supported by positive visual acuity gains found in the phase 3 QUASAR trial. This is…
Nov 24, 2025
GLP-1s may double risk for development of wet AMD
By Justin Cooper Fact checked by; Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and adjusted models.…
Nov 24, 2025
EYE on MACULAR CAROTENOIDS: Diet & Supplementation
You’ve heard of Vitamin A for your eyes… but did you know there’s a family of natural pigments that may be even more essential for protecting your vision? 👁️ In…
Nov 21, 2025
8 Foods That Fight Inflammation Even Better Than Ginger
By Anna Giorgi Published on November 18, 2025 Medically reviewed by Karina Tolentino, RD Ginger is one of several foods that may have strong anti-inflammatory effects. Ginger isn’t the only anti-inflammatory food,…
Nov 18, 2025
Enjoying the Winter Wonderland: A Winter Eyecare Guide
As winter sets in, many of us may experience symptoms that differ from those in other times of the year. One common issue that tends to worsen in winter…
Nov 18, 2025
Apellis announces 5-year GALE study data in GA
Author(s): Kassi Filkins Fact checked by: Kirsty Mackay Key Takeaways SYFOVRE (pegcetacoplan injection) delays GA lesion growth by approximately 1.5 years compared to sham treatment in AMD patients. The GALE study,…
Nov 17, 2025
The Eye Q Podcast Episode 49
In this episode of The Eye-Q Podcast, Dr. Rani Banik sits down with Dr. Debbie Ozment—an integrative dentist with over 40 years of experience—to explore the mouth-body connection. They discuss…
Nov 11, 2025
Happy Veterans Day
Happy Veterans Day. Thank you to all who serve and their families for their sacrifices. “As we express our gratitude, we must never forget that the highest appreciation is not…
Nov 7, 2025
eSight Go headset ‘gives you your central perception back’
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: eSight Go uses two OLED screens to boost visual acuity for people with central vision loss. The device is…
Nov 6, 2025
GLP-1s may double risk for development of wet AMD
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and adjusted models.…
Nov 5, 2025
Smart eye wear ‘definitely having a moment’ with jump in consumer awareness
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Consumers are more familiar with smart eye wear than they were 2 years ago. Social media is the main…
Nov 4, 2025
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
Author(s) : Martin David Harp Key Takeaways AXPAXLI is a bioresorbable hydrogel incorporating axitinib, targeting wet AMD and other retinal diseases with anti-angiogenic properties. The SOL-R trial compares AXPAXLI’s six-month dosing…
Oct 30, 2025
Research supports that iron dysregulation may drive AMD
Author(s): Sydney M Crago Key Takeaways Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD and GA. Transferrin, regulating iron homeostasis, is a potential…
Oct 24, 2025
Starting from scratch on neovascular age-related macular degeneration
Author(s): Lynda Charters Key Takeaways Gene therapy for nAMD offers potential to reduce treatment burden and improve vision, but long-term safety and efficacy remain concerns. Various gene delivery systems, including…
Oct 16, 2025
Consumer technology has limitations for assistive needs
By: Roland Mattern Fact checked by: Christine Klimanskis, ELS Key takeaways: Accessibility features in mainstream technology are not as reliable as those in dedicated assistive devices. Purpose-built assistive technology has…
Oct 10, 2025
Sharper vision starts here
Sharper vision starts here Author(s)Jack M. Chapman, MD Fact checked by: Sheryl Stevenson Key Takeaways Over 75% of cataract patients have preoperative corneal astigmatism, yet toric IOLs are used in only…
Oct 10, 2025
Seeing Stars: Gould & Steele interview
Permission was given by Martha Steele & Ellen Gould to share this podcast.
Oct 8, 2025
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
Publication|Articles|October 6, 2025 Optometry Times Journal September/October digital edition 2025- Volume 17 – Issue 05 Author(s)Lynda Charters Fact checked by: Karen S. DeLoss, OD, FAAO Eye care providers are uniquely positioned to…
Sep 26, 2025
Seeing Through the Fog: Understanding Macular Degeneration
Helping with reading, driving, and daily tasks, caregivers often serve as the ‘eyes’ for their loved ones By: Paul Wynn,AARP In her early 40s, Jan* began noticing subtle but troubling…
Sep 23, 2025
New eyedrop raises hopes for less invasive treatment of serious vision conditions
A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions. The…
Sep 23, 2025
Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration
Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration by: Michigan Medicine-University of Michigan Newswise — In the United States, age-related macular degeneration is a leading…
Sep 16, 2025
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Recruiting- Phase 2 ClinicalTrials.gov IDNCT06635148 SponsorJanssen Research & Development, LLC Information Provided byJanssen Research & Development, LLC Clinical Trial Study Start (Actual)2024-09-19 Primary Completion (Estimated) 2029-08-24 Study Completion (Estimated)2030-06-27 Enrollment (Estimated)311…
Sep 16, 2025
FDA fast tracks SAR402663 intravitreal gene therapy for wet AMD
By:Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR402663 is a one-time intravitreal gene therapy designed to reduce treatment burden. It is currently being investigated in a phase…
Sep 12, 2025
Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report
Author(s): Martin David Harp Key Takeaways TearCare System’s inclusion in TFOS DEWS III report validates its clinical efficacy and role in dry eye management. Data from studies such as SAHARA…
Sep 9, 2025
A study of the progression of sensitivity loss in GA over time using inferred data
Author(s): Lynda Charters Key Takeaways Inferred sensitivity mapping predicts retinal function in GA with high spatial resolution, avoiding extensive psychophysical testing. Current GA treatments slow progression but lack functional benefits;…
Sep 2, 2025
First patient dosed in Qlaris Bio’s phase 2 Nightingale clinical trial for QLS-111
By: Jordana Joy, Associate Editor The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma. The first patient has been dosed…
Sep 2, 2025
Inside genetics and glaucoma
August 28, 2025 By Kyra Dorgeloh, OD, FAAO Thomas A. Wong, OD, FAAO Glaucoma is a general term for a diverse group of complex disorders characterized by progressive degeneration of the…